Log in
Show password
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 


SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Wall Street bounces back from Omicron, inflation jitters

12/01/2021 | 12:26pm EST

(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window.)

* Merck up as FDA panel narrowly votes to back COVID pill

* Private payrolls, factory activity increase in November

* Salesforce falls on disappointing profit forecast

* Indexes up: Dow 1.03%, S&P 1.46%, Nasdaq 1.22%

Dec 1 (Reuters) - Wall Street's main indexes rebounded more than 1% on Wednesday as investors appeared to look past concerns over rising inflation and the new Omicron coronavirus variant, while shares of Merck rose on progress in approval of its COVID-19 pill.

Merck & Co Inc gained 1.9% after a panel of advisers to the U.S. Food and Drug Administration narrowly voted to recommend the agency authorize the drugmaker's antiviral pill to treat COVID-19.

All of the 11 major S&P sectors advanced in a broad-based rally, with energy and utilities shares jumping more than 2% each.

Banks added 1.7%, recouping some losses suffered in the previous session.

Shares of mega-cap technology titans Amazon.com, Apple Inc, Tesla Inc, Google owner Alphabet Inc and Microsoft Corp, which are favored at times of uncertainty, added between 0.8% and 2.5% to provide the biggest boost to S&P 500 and the Nasdaq.

"People are just confident in the earnings predictability of tech stocks," said Andre Bakhos, managing director at New Vines Capital LLC in Bernardsville, New Jersey.

In a hearing before the House Committee on Financial Services, Federal Reserve Chair Jerome Powell reiterated his comments from Tuesday about considering the acceleration of taper at the central bank's December meeting amid a surge in inflation and a stronger economy.

Powell said the Fed's two goals of price stability and jobs recovery are in tension and that it will use tools to make sure high inflation does not become entrenched.

U.S. stocks slumped on Tuesday after Powell's hawkish tone served as a double whammy for markets, which were already nervous about the spread of the Omicron variant and its potential to hinder a global economic recovery.

"We're seeing uncertainty manifest with a high level of volatile price action, as investors get their heads around what Powell's comments mean, and keeping their finger on the pulse of Omicron," Bakhos said.

Market participants were also awaiting a Fed report, known as the "Beige Book", on current economic conditions to provide further insight into the central bank's stance on inflation. The report is due at 2:00 p.m. ET (1900 GMT).

The World Health Organization expects to have more information on the transmissibility of the Omicron variant within days, and that the agency believes the existing COVID-19 vaccines will work against the variant.

At 11:57 a.m. ET, the Dow Jones Industrial Average was up 355.41 points, or 1.03%, at 34,839.13, the S&P 500 was up 66.83 points, or 1.46%, at 4,633.83, and the Nasdaq Composite was up 189.11 points, or 1.22%, at 15,726.80.

Meanwhile, separate data showed U.S. private employers maintained a strong pace of hiring in November, while factory activity rose slightly as input prices eased, new orders gathered steam and the employment situation improved marginally.

Salesforce.com Inc forecast current-quarter profit below estimates as it faces stiff competition from rivals including Microsoft, sending its shares down 6.7%.

Advancing issues outnumbered decliners by a 3.30-to-1 ratio on the NYSE and by a 2.35-to-1 ratio on the Nasdaq.

The S&P index recorded 10 new 52-week highs and three new lows, while the Nasdaq recorded 28 new highs and 83 new lows. (Reporting by Devik Jain, Ambar Warrick and Medha Singh in Bengaluru; Editing by Shounak Dasgupta and Maju Samuel)

ę Reuters 2021
Stocks mentioned in the article
ChangeLast1st jan.
ALPHABET INC. -2.22% 2607.03 Delayed Quote.-7.97%
AMAZON.COM, INC. -5.95% 2852.86 Delayed Quote.-14.44%
APPLE INC. -1.28% 162.41 Delayed Quote.-7.35%
MICROSOFT CORPORATION -1.85% 296.03 Delayed Quote.-10.32%
TESLA, INC. -5.26% 943.9 Delayed Quote.-10.68%
01/21US Stocks Slump to New 2022 Lows Friday; Nasdaq Down 12% This Month as Netflix Dives
01/21Workers at Activision Blizzard-owned studio say they have formed union
01/21SOCIAL BUZZ : Wallstreetbets Stocks Broadly Slide, Led by Netflix
01/21MICROSOFT : Xbox celebrates the Year of the Tiger with the ‘Luckiest Xbox Series S'
01/21Wall Street slide deepens after Netflix disappointment
01/21MINECRAFT STREAMERS : Compete for $30,000 in Game Pass Has PC Games Invitational with Boom..
01/21MICROSOFT : Celebrating 20 years of Trustworthy Computing
01/21MICROSOFT : What's new in Microsoft 365 accessibility features to create content that ever..
01/21Sony Shares Drop After Microsoft, Activision Deal Announcement 'Overly Negative,' Oppen..
01/21Single stock options worth $1.2 trillion set to expire - Options Solutions
More news
Analyst Recommendations on MICROSOFT CORPORATION
More recommendations
Financials (USD)
Sales 2022 197 B - -
Net income 2022 71 463 M - -
Net cash 2022 89 063 M - -
P/E ratio 2022 31,2x
Yield 2022 0,80%
Capitalization 2 223 B 2 223 B -
EV / Sales 2022 10,9x
EV / Sales 2023 9,40x
Nbr of Employees 181 000
Free-Float -
Duration : Period :
Microsoft Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MICROSOFT CORPORATION
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus BUY
Number of Analysts 45
Last Close Price 296,03 $
Average target price 373,06 $
Spread / Average Target 26,0%
EPS Revisions
Managers and Directors
Satya Nadella Chairman & Chief Executive Officer
Bradford L. Smith President & Chief Legal Officer
Amy E. Hood Chief Financial Officer & Executive Vice President
James Kevin Scott Chief Technology Officer & Executive VP
Matthias Troyer Partner Research Manager
Sector and Competitors
1st jan.Capi. (M$)
SEA LIMITED-30.98%86 769
SYNOPSYS INC.-17.69%46 539